Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.
|
|
Los Angeles Times (12.20.02) - Monday, December 23, 2002
Solomon Moore
Debswana Diamond Co. in Botswana is the first company in the region to offer voluntary HIV testing and to cover costs of employee's antiretroviral drugs. "Debswana is the model for our country," said Dr. Banu Khan, head of Botswana's AIDS programs. "Antiretroviral therapies will lead to AIDS prevention, they will prevent children from becoming orphans, they will prolong life."
Other companies have followed Debswana's lead. In South Africa, DaimlerChrysler, Coca-Cola and Barclay's Bank are among the dozens of businesses offering antiretroviral treatment and AIDS awareness programs. "We're stepping in because the government isn't," said Errol Sackstein, general director of pen manufacturer Bic South Africa.
Brian Brink, senior vice president of mining conglomerate Anglo American, said he recognized the "monstrous challenge facing [South Africa's] government in dealing with people who are unemployed, have poor nutrition, no sanitation, lack housing. But you can start, and I would argue that you could begin with the economically active people that you need to keep the country moving." Brink noted that providing AIDS therapies was a matter of enlightened self-interest for his company. "When ... you've got sickness and death all around you, when you're going to funerals every weekend - all these things are going to have a negative impact on morale and productivity," he said.
As welcome as these private programs are, most companies only provide medicine for employees and a spouse. Many African men have more than one wife, and no medicine is provided for the children. Both patients and businesses suffer the stigma HIV/AIDS carries in African culture.
021223
AD022480
Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.